0.53 USD
▲+0.01+7.56%
盘后 0.50 +1.63%
2026-08-03
市值
$51.89M
市盈率
—
EPS
-0.73
股息率
—
52 周区间
0.40 – 6.50
成交量
974.96K
Beta
0.53
目标价
2.86
52W 低 0.4052W 高 6.50
价格走势
公司简介
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs); and treatment of other ILDs, such as chronic hypersensitivity pn...